Analysts/Institutional Investor Meet/Con. Call Updates

July 16, 2026 The National Stock Exchange of India Limited BSE Limited Exchange Plaza Phiroze Jeejeeboy Towers B(SaYnMdeBrOa LK:u TrHlaY CRoOmCpAleRxE, ) (DSaClRalI PSt CreOeDt, E 539871) Bandra (E), Mumbai - 400 051 Mumbai- 400 001 Sub : Invite for Earnings Conference Call Ref : Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Madam, Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to intimate that conference call for the analysts/investors is arranged by our management to discuss the Company’s Unaudited Financial Results for the quarter ended June 30, 2026, on Thursday, July 23, 2026, at 6:00 P.M. (IST). Dial-in details are given in the copy of the enclosed invite. This is for your information and records. Thyrocare Technologies Limited, Yours Faithfully, Brijesh Kumar Company Secretary and Compliance Officer Encl: A/a Thyrocare Q1FY27/FY2026-27 Earnings Call Thursday, July 23, 2026, 06:00 PM (IST) Thyrocare Technologies Limited Invites you to interact with the Senior Management on Q1FY27/FY2026-27 earnings Speakers: Mr. Rahul Guha, Chairman, MD & CEO Mr. Rajdeep Panwar, CCO Dr. Ramesh Kinha, COO Mr. Vikram Gupta, CFO Mr. Preet Joshi, Manager - Strategy & Investor Relations Conference Call Details Dial in Details: ForThyrocare’sConferenceCall, Thursday, July 23, 2026, 06:00 PM (IST) Universal Access +91 22 6280 1408 +91 22 7115 8296 Copy this URL in your browser https://services.choruscall.in/DiamondPassRegistration/register?confirmation (for early registration) Number=1301004&linkSecurityString=b03e0e090 Webcast Link https://event.choruscall.com/mediaframe/webcast.html?webcastid=IM2sFqJl